Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NERV - Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake

NERV - Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake

Minerva Neurosciences Inc

  • Minerva Neurosciences ( NASDAQ: NERV ) is up 75% in Wednesday afternoon trading following an SEC filing stating that Point72 Capital Advisors has an 8.8% stake in the company.
  • The company reached a high today of $8.58 per share, though that is still well below the 52-week high of $16.80.
  • The filing, posted after Tuesday's closing bell, states that Point72 has 470K outstanding shares.
  • Steven A. Cohen is founder of Point72.
  • Minerva ( NERV ) is focused on treatments for central nervous system diseases. Its lead candidate, roluperidone, is in phase 3 for schizophrenia.
  • Seeking Alpha's Quant Rating views Minerva ( NERV ) as a hold with strong grades for revisions and momentum .

For further details see:

Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake
Stock Information
Company Name: Minerva Neurosciences Inc
Stock Symbol: NERV
Market: NASDAQ
Website: minervaneurosciences.com
Menu
NERV NERV Quote NERV Short NERV News NERV Articles NERV Message Board
Get NERV Alerts

News, Short Squeeze, Breakout and More Instantly...